[1]
S. Asif, S. N. Mahmood, and O. K. Naveed, “Posterior Reversible Leukoencephalopathy Syndrome in a patient after second dose of Rituximab for treatment of resistant Thrombotic Thrombocytopenic Purpura”, J Clini Nephrol, vol. 2, no. 1, pp. 001–004, Feb. 2018.